Liu-Hua Hu

Liu-Hua Hu

Auto-generated profile, based on publicly available information

Liu-Hua Hu

Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XWXiao-Lei Wang
Xiao-Lei Wang
TZTuo Zhang
Tuo Zhang
LHLiu-Hua Hu
Liu-Hua Hu
SSShi-Qun Sun
Shi-Qun Sun
WZWei-Feng Zhang
Wei-Feng Zhang
BHBen He
Ben He
Statins are a promising new strategy to prevent contrast‐induced acute kidney injury (CI‐AKI). In this study we compared the ameliorative effect of different statins in a rat model of CI‐AKI. Sprague‐Dawley rats were divided into five groups: control group; CI‐AKI group; CI‐AKI + rosuvastatin group (10 mg/kg/day); CI‐AKI + simvastatin group (80 mg/kg/day); and CI‐AKI + atorvastatin group (20 mg/kg/day). CI‐AKI was induced by dehydration for 72 hours, followed by furosemide intramuscular injection 20 minutes before low‐osmolar contrast media (CM) intravenous injection. Statins were administered by oral gavage once daily for 3 consecutive days before CM injection and once 4 hours after CM injection. Rats were sacrificed 24 hours after CM injection, and renal function, kidney histopathology, nitric oxide (NO) metabolites, and markers of oxidative stress, inflammation, and apoptosis were evaluated. The results showed that atorvastatin and rosuvastatin but not simvastatin ameliorated CM‐induced serum creatinine elevation and histopathological alterations. Atorvastatin and rosuvastatin showed similar effectiveness against CM‐induced oxidative stress, but simvastatin was less effective. Atorvastatin was most effective against NO system dysfunction and cell apoptosis, whereas rosuvastatin was most effective against inflammation. Our findings indicate that statins exhibit differential effects in preventing CI‐AKI when given at equivalent lipid‐lowering doses.